Generation Bio Stock (NASDAQ: GBIO) stock price, news, charts, stock research, profile.
Open | $3.220 |
Close | $2.990 |
Volume / Avg. | 114.491K / 240.406K |
Day Range | 2.980 - 3.224 |
52 Wk Range | 0.860 - 6.980 |
Market Cap | $198.767M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 2.93% |
Days to Cover | 5.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Generation Bio (NASDAQ: GBIO) through any online brokerage.
Other companies in Generation Bio’s space includes: Zura Bio (NASDAQ:ZURA), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Century Therapeutics (NASDAQ:IPSC).
The latest price target for Generation Bio (NASDAQ: GBIO) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 10.00 expecting GBIO to rise to within 12 months (a possible 234.45% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Generation Bio (NASDAQ: GBIO) is $2.99 last updated April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Generation Bio.
Generation Bio’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Generation Bio.
Generation Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.